Bayan Takizawa

Role: Co-founder, Chief Business Officer at Continuus Pharmaceuticals
Location: Cambridge, MA, US
LinkedIn followers: 500 followers

General Business & ManagementView LinkedIn profile

Experience

Co-founder, Chief Business Officer
Continuus Pharmaceuticals
Jun 2013 — Present
Continuous manufacturing of small-molecule pharmaceuticals

Education

Yale School of Medicine
M.D., Medicine
1997 — 2002
Massachusetts Institute of Technology
S.M., Engineering Systems
2009 — 2011
Cornell University
B.S., Chemical Engineering
1993 — 1997
MIT Sloan School of Management
M.B.A.
2009 — 2011

Skills

Lifesciences
Biotechnology
Strategy
Consulting
Pharmaceutical Industry
Medical Devices
Business Planning
Healthcare Consulting
Management Consulting
Cancer
Life Sciences
Healthcare
Venture Capital
Financial Modeling
Surgery
Medicine
Leadership
Start-Ups

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@continuuspharma.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Continuus Pharmaceuticals

Pharmaceutical Manufacturing · 21 employees · Founded 2012 · Woburn, Massachusetts, United States

CONTINUUS’ mission is to produce high-quality drugs that can be delivered to patients more effectively and at a lower cost. In achieving this goal, we look to radically transform the pharmaceutical manufacturing industry, steering it away from outdated batch systems to state-of-the-art continuous processes. CONTINUUS is leveraging a novel continuous manufacturing platform called Integrated Continuous Manufacturing (ICM), initially developed through an $85 M joint research project between Novartis and MIT. With ICM, we will improve affordability and accessibility of pharmaceuticals on a global scale. Our work is critical because the current manufacturing systems are time- and cost-inefficient, and are beset with quality problems. It is not unusual for manufacturing lead times, from start to finish, to be over one year, and studies have shown that the industry loses over $50 B annually due to wasteful processes. More importantly, these problems impact patient care. Hundreds of drugs are placed on the US FDA drug shortage website, many of which are life-saving (e.g, oncology drugs). To solve these problems, we offer a number of solutions. To achieve our goals, CONTINUUS has assembled a team of talented engineers and scientists, with skills ranging from analytical chemistry to drug formulation. Rather than producing medicines through batch-wise, step-by-step processes, ICM allows for fully continuous and automated operations, where the synthesis of the active ingredient and the final dosage form are integrated into a seamless process. This novel method will allow “on-demand” manufacturing of pharmaceuticals, improving affordability and accessibility of pharmaceuticals on a global scale.

continuuspharma.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Experience

Co-founder, Chief Business Officer

Education

Yale School of Medicine

Massachusetts Institute of Technology

Cornell University

MIT Sloan School of Management

Skills

Find verified contacts for anyone on LinkedIn